These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

472 related articles for article (PubMed ID: 31479276)

  • 21. Capillary Zone Electrophoresis-Tandem Mass Spectrometry with Activated Ion Electron Transfer Dissociation for Large-scale Top-down Proteomics.
    McCool EN; Lodge JM; Basharat AR; Liu X; Coon JJ; Sun L
    J Am Soc Mass Spectrom; 2019 Dec; 30(12):2470-2479. PubMed ID: 31073891
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Top-Down Proteomics and the Challenges of True Proteoform Characterization.
    Po A; Eyers CE
    J Proteome Res; 2023 Dec; 22(12):3663-3675. PubMed ID: 37937372
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Top-down protein identification using isotopic envelope fingerprinting.
    Xiao K; Yu F; Tian Z
    J Proteomics; 2017 Jan; 152():41-47. PubMed ID: 27989944
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Capillary zone electrophoresis-mass spectrometry for top-down proteomics.
    Shen X; Yang Z; McCool EN; Lubeckyj RA; Chen D; Sun L
    Trends Analyt Chem; 2019 Nov; 120():. PubMed ID: 31537953
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantitation and Identification of Thousands of Human Proteoforms below 30 kDa.
    Durbin KR; Fornelli L; Fellers RT; Doubleday PF; Narita M; Kelleher NL
    J Proteome Res; 2016 Mar; 15(3):976-82. PubMed ID: 26795204
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A graph-based approach for proteoform identification and quantification using top-down homogeneous multiplexed tandem mass spectra.
    Zhu K; Liu X
    BMC Bioinformatics; 2018 Aug; 19(Suppl 9):280. PubMed ID: 30367573
    [TBL] [Abstract][Full Text] [Related]  

  • 27. TopPIC: a software tool for top-down mass spectrometry-based proteoform identification and characterization.
    Kou Q; Xun L; Liu X
    Bioinformatics; 2016 Nov; 32(22):3495-3497. PubMed ID: 27423895
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Deep Intact Proteoform Characterization in Human Cell Lysate Using High-pH and Low-pH Reversed-Phase Liquid Chromatography.
    Yu D; Wang Z; Cupp-Sutton KA; Liu X; Wu S
    J Am Soc Mass Spectrom; 2019 Dec; 30(12):2502-2513. PubMed ID: 31755044
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thorough Performance Evaluation of 213 nm Ultraviolet Photodissociation for Top-down Proteomics.
    Fornelli L; Srzentić K; Toby TK; Doubleday PF; Huguet R; Mullen C; Melani RD; Dos Santos Seckler H; DeHart CJ; Weisbrod CR; Durbin KR; Greer JB; Early BP; Fellers RT; Zabrouskov V; Thomas PM; Compton PD; Kelleher NL
    Mol Cell Proteomics; 2020 Feb; 19(2):405-420. PubMed ID: 31888965
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Coupling Capillary Zone Electrophoresis to a Q Exactive HF Mass Spectrometer for Top-down Proteomics: 580 Proteoform Identifications from Yeast.
    Zhao Y; Sun L; Zhu G; Dovichi NJ
    J Proteome Res; 2016 Oct; 15(10):3679-3685. PubMed ID: 27490796
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of Proteoform Post-Translational Modifications by Top-Down and Bottom-Up Mass Spectrometry in Conjunction with Annotations.
    Chen W; Ding Z; Zang Y; Liu X
    J Proteome Res; 2023 Oct; 22(10):3178-3189. PubMed ID: 37728997
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High-throughput quantitative top-down proteomics.
    Cupp-Sutton KA; Wu S
    Mol Omics; 2020 Apr; 16(2):91-99. PubMed ID: 31932818
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Human Proteoform Atlas: a FAIR community resource for experimentally derived proteoforms.
    Hollas MAR; Robey MT; Fellers RT; LeDuc RD; Thomas PM; Kelleher NL
    Nucleic Acids Res; 2022 Jan; 50(D1):D526-D533. PubMed ID: 34986596
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inventory of proteoforms as a current challenge of proteomics: Some technical aspects.
    Naryzhny S
    J Proteomics; 2019 Jan; 191():22-28. PubMed ID: 29777872
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Top-Down Proteomics Enables Comparative Analysis of Brain Proteoforms Between Mouse Strains.
    Davis RG; Park HM; Kim K; Greer JB; Fellers RT; LeDuc RD; Romanova EV; Rubakhin SS; Zombeck JA; Wu C; Yau PM; Gao P; van Nispen AJ; Patrie SM; Thomas PM; Sweedler JV; Rhodes JS; Kelleher NL
    Anal Chem; 2018 Mar; 90(6):3802-3810. PubMed ID: 29481055
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Accurate Estimation of Context-Dependent False Discovery Rates in Top-Down Proteomics.
    LeDuc RD; Fellers RT; Early BP; Greer JB; Shams DP; Thomas PM; Kelleher NL
    Mol Cell Proteomics; 2019 Apr; 18(4):796-805. PubMed ID: 30647073
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Spatially Resolved Top-Down Proteomics of Tissue Sections Based on a Microfluidic Nanodroplet Sample Preparation Platform.
    Liao YC; Fulcher JM; Degnan DJ; Williams SM; Bramer LM; Veličković D; Zemaitis KJ; Veličković M; Sontag RL; Moore RJ; Paša-Tolić L; Zhu Y; Zhou M
    Mol Cell Proteomics; 2023 Feb; 22(2):100491. PubMed ID: 36603806
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of bottom-up and top-down mass spectrum identifications with different customized protein sequences databases.
    Li Z; He B; Feng W
    Bioinformatics; 2020 Feb; 36(4):1030-1036. PubMed ID: 31584612
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Proteoforms and Proteoform Families: Past, Present, and Future.
    Smith LM
    Methods Mol Biol; 2022; 2500():1-4. PubMed ID: 35657582
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mass spectrometry-based proteomics analyses of post-translational modifications and proteoforms in human pituitary adenomas.
    Li J; Zhan X
    Biochim Biophys Acta Proteins Proteom; 2021 Mar; 1869(3):140584. PubMed ID: 33321259
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.